48North Joins Forces with Mother & Clone to License Sublingual Nanospray in Canada
Ryan Allway
October 2nd, 2018
Exclusive, News, Top Story
Market Trends
Women, overall, are responsible for 70-80% of consumer spending and the burgeoning cannabis market is no different than any other in this respect. Studies are showing that female consumers are embracing cannabis from both a health & wellness and recreational standpoint, and they want cannabis products that are discreet, easy to consume, and don’t affect their ability to function in their day-to-day activities.
Now two key specialty players in the women’s cannabis sector have joined forces to develop products focused on these particular women’s buying trends.
A Perfect Union
48North Cannabis Corp (TSX-V: NRTH) has announced that it has entered into a licensing agreement with Mother & Clone, Inc. (“Mother & Clone“), a Colorado-based company producing proprietary cannabis sublingual nanosprays (a form of measured microdosing).
Canadian production and sale of Mother & Clone products are expected to commence after 48North receives its Health Canada license amendment permitting the sale of cannabis oil since the Company already holds a supplemental license for the extraction and production of cannabis oil.
Per the licensing agreement, 48North will be the exclusive Canadian licensed producer of all present and future Mother & Clone products for domestic Canadian consumption and global export. Mother & Clone will earn a ten percent licensing fee on the gross profit on all Canadian and international sales. The agreement provides for production from the unique cultivars grown at 48North’s state-of-the-art, closed-box, 40,000-square-foot DelShen facility, using existing the research and development of Mother & Clone’s proprietary, strain-specific nano-particle delivery system.
A Strategic Alliance for a Worldwide Niche Market
“It is fitting that our first official partnership and portfolio addition is with Mother & Clone, a woman-led and focused cannabis company with a unique product offering,” said Alison Gordon, Chief Executive Officer at 48North. “This deal includes product distribution, brand familiarity and intellectual property ownership over all Mother & Clone products and will give us a competitive lead in bringing next-generation wellness products to the Canadian and international markets.”
“Partnering with 48North aligns with Mother & Clone’s brand positioning, corporate values and shared focus on women’s lifestyle and wellness through cannabis in the adult recreational space,” said Leslie Siu, Chief Executive Office of Mother & Clone.
Because Mother & Clone‘s strain-specific sublingual products are uniquely formulated for rapid absorption under the tongue, with effects that are felt within minutes and last about an hour, these worry-free Ph.D. formulated cannabis products are likely to appeal to cannabis-minded women.
Growing Trends in Female Cannabis Consumption
According to a recent survey from BDS Analytics, menstruation, menopause, and sex were listed as the top reasons for female cannabis consumption. As part of its Cannabis Wellness Trends Series, BDS Analytics recently conducted a consumer insights survey of 1,281 women in four states where cannabis sales are legal, California, Colorado, Oregon and Washington.
The study revealed that, at least in the women’s market, cannabis consumption was common across all ages. Younger women are increasingly turning to marijuana as a natural alternative to manage mood swings and premenstrual pain, and older women, transitioning through menopause, choosing cannabis products to supplement or replace estrogen therapy and improve their sleep. Additionally, 25% of women consumers reported reduced use of prescription medications, and 33% reported reduced use of over-the-counter medications since starting a cannabis regimen. Women are clearly taking a bigger interest in cannabis-based products in areas where recreational use is approved.
Looking Ahead
With the legalization of recreational cannabis in Canada, the health and wellness market is garnering a greater interest in incorporating more cannabis-based products for domestic use in Canada, as well as future opportunities for exporting to markets around the world. Investors are taking note of these kinds of market trends and paying special attention to public companies that are taking a leading edge in the cannabis health and wellness sector. 48North Cannabis Corp (TSX-V: NRTH), with its unique niche market, is one such company to watch.
For more information, visit the company’s website at www.48nrth.com.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
The Yield Growth Corp. is a diverse team of business executives dedicated to rapid, sustainable financial growth for businesses with viable models for success.
The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe and Latin America and the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
